Fareva Amboise
PolandAll drugs from this manufacturer
-
The medicine is intended for the symptomatic treatment of mild to moderate dementia in Alzheimer's disease in adults.
Dosage form: tablets, film-coated
Active substance Dosage donepezil hydrochloride 5 mg ATC: N06DA02
-
The medicine is intended for the symptomatic treatment of mild to moderate dementia in Alzheimer's disease in adults.
Dosage form: tablets, film-coated
Active substance Dosage donepezil hydrochloride 10 mg ATC: N06DA02
-
It is an antibiotic used, among other things, to treat infections of the bones and joints, otitis media (middle ear infection), throat, sinuses, teeth and oral cavity, lower respiratory tract, pelvis, abdomen, female genital organs, skin and soft tissues, as well as in the treatment of scarlet fever, septicaemia, and endocarditis.
Dosage form: capsules
Active substance Dosage clindamycin hydrochloride 75 mg ATC: J01FF01
-
It is an antibiotic used to treat various bacterial infections, such as infections of the bones and joints, middle ear, throat, sinuses, teeth, oral cavity, respiratory tract, pelvis, abdomen, genitals, skin and soft tissues, as well as in the treatment of scarlet fever, septicaemia, and endocarditis.
Dosage form: capsules
Active substance Dosage clindamycin hydrochloride 150 mg ATC: J01FF01
-
It is an antibiotic used to treat various bacterial infections, such as bone and joint infections, otitis media (middle ear infection), throat, sinus, dental and oral infections, respiratory tract, pelvic, abdominal, genital, skin and soft tissue infections, as well as in the treatment of scarlet fever, septicaemia, and endocarditis.
Dosage form: capsules
Active substance Dosage clindamycin 300 mg ATC: J01FF01
-
The medicine is used to treat infections caused by pathogenic fungi (e.g., cryptococcal meningitis, coccidioidomycosis, or Candida yeast infections) and to prevent these infections or their recurrence.
Dosage form: solution for infusion
Active substance Dosage fluconazole 2 mg/ml ATC: J02AC01
-
The medicine is intended for the treatment of type 2 diabetes (non-insulin dependent) when adequate blood sugar levels cannot be maintained by diet alone.
Dosage form: tablets, prolonged release
Active substance Dosage glipizide 5.49 mg ATC: A10BB07
-
The medicine is used to treat type 2 diabetes (insulin-independent) when proper blood sugar levels cannot be maintained by diet alone.
Dosage form: tablets, prolonged release
Active substance Dosage glipizide 10.98 mg ATC: A10BB07
-
The medicine is used to treat heart failure to prevent it from worsening and to reduce the number of hospitalizations. It is used in people who have recently suffered a heart attack (in combination with other medicines) or in patients with persistent, mild symptoms despite previous treatment.
Dosage form: tablets, film-coated
Active substance Dosage eplerenone 25 mg ATC: C03DA04
-
The medicine is used to treat heart failure to prevent its worsening and to reduce the risk of hospitalization. It is intended for people who have recently had a heart attack or who continue to have mild symptoms despite ongoing treatment.
Dosage form: tablets, film-coated
Active substance Dosage eplerenone 50 mg ATC: C03DA04